The combination of PD-1 and PD-L1 weakens the ability of T cells to kill tumors, inhibits T-cell receptor-mediated cytokine secretion and lymphocyte proliferation, and ultimately leads to tumor cells evading the immune system (Freeman et al., 2000). This evidence concerns the gene CD274 and neoplasm.